Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

Gwen Wyatt Discusses Complementary Therapies

Wednesday, May 01, 2013
Gwen Wyatt, PhD, RN, Professor, College of Nursing, Michigan State University, discusses the use of complementary therapies in cancer care.

The latest research, Wyatt says, shows that 80% of patients with breast cancer use complementary therapies. This is a compelling fact and can be problematic if these therapies are being used without adequate safety and efficacy knowledge. Though many complementary therapies do not have safety concerns, there is a need for evidence to support that.

In the case of ingestible therapies such as herbs or botanicals, these can interfere with medical management or cause other symptoms. Wyatt believes that patients will use complementary therapies even in the absence of evidence to support their benefit.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.